Computational binding assays of antigenic peptides

Vladimir Brusic, John Zeleznikow

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Computer models can be combined with laboratory experiments for the efficient determination of (i) peptides that bind MHC molecules and (ii) T- cell epitopes. For maximum benefit, the use of computer models must be treated as experiments analogous to standard laboratory procedures. This requires the definition of standards and experimental protocols for model application. We describe the requirements for validation and assessment of computer models. The utility of combining accurate predictions with a limited number of laboratory experiments is illustrated by practical examples. These include the identification of T-cell epitopes from IDDM-, melanoma- and malaria-related antigens by combining computational and conventional laboratory assays. The success rate in determining antigenic peptides, each in the context of a specific HLA molecule, ranged from 27 to 7 1%, while the natural prevalence of MHC-binding peptides is 0.1-5%.

Original languageEnglish
Pages (from-to)313-324
Number of pages12
JournalLetters in Peptide Science
Volume6
Issue number5-6
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Peptides
Assays
Computer Simulation
Epitopes
T-Lymphocyte Epitopes
T-cells
Molecules
Experiments
Antigens
Type 1 Diabetes Mellitus
Malaria
Melanoma
Theoretical Models

Keywords

  • Antigenic peptides
  • Computer models
  • HLA
  • MHC
  • Prediction
  • T-cell epitopes

ASJC Scopus subject areas

  • Biochemistry

Cite this

Brusic, V., & Zeleznikow, J. (1999). Computational binding assays of antigenic peptides. Letters in Peptide Science, 6(5-6), 313-324.

Computational binding assays of antigenic peptides. / Brusic, Vladimir; Zeleznikow, John.

In: Letters in Peptide Science, Vol. 6, No. 5-6, 1999, p. 313-324.

Research output: Contribution to journalArticle

Brusic, V & Zeleznikow, J 1999, 'Computational binding assays of antigenic peptides', Letters in Peptide Science, vol. 6, no. 5-6, pp. 313-324.
Brusic, Vladimir ; Zeleznikow, John. / Computational binding assays of antigenic peptides. In: Letters in Peptide Science. 1999 ; Vol. 6, No. 5-6. pp. 313-324.
@article{88823fda470f478b95045fab979c01fc,
title = "Computational binding assays of antigenic peptides",
abstract = "Computer models can be combined with laboratory experiments for the efficient determination of (i) peptides that bind MHC molecules and (ii) T- cell epitopes. For maximum benefit, the use of computer models must be treated as experiments analogous to standard laboratory procedures. This requires the definition of standards and experimental protocols for model application. We describe the requirements for validation and assessment of computer models. The utility of combining accurate predictions with a limited number of laboratory experiments is illustrated by practical examples. These include the identification of T-cell epitopes from IDDM-, melanoma- and malaria-related antigens by combining computational and conventional laboratory assays. The success rate in determining antigenic peptides, each in the context of a specific HLA molecule, ranged from 27 to 7 1{\%}, while the natural prevalence of MHC-binding peptides is 0.1-5{\%}.",
keywords = "Antigenic peptides, Computer models, HLA, MHC, Prediction, T-cell epitopes",
author = "Vladimir Brusic and John Zeleznikow",
year = "1999",
language = "English",
volume = "6",
pages = "313--324",
journal = "International Journal of Peptide Research and Therapeutics",
issn = "1573-3149",
publisher = "Springer Netherlands",
number = "5-6",

}

TY - JOUR

T1 - Computational binding assays of antigenic peptides

AU - Brusic, Vladimir

AU - Zeleznikow, John

PY - 1999

Y1 - 1999

N2 - Computer models can be combined with laboratory experiments for the efficient determination of (i) peptides that bind MHC molecules and (ii) T- cell epitopes. For maximum benefit, the use of computer models must be treated as experiments analogous to standard laboratory procedures. This requires the definition of standards and experimental protocols for model application. We describe the requirements for validation and assessment of computer models. The utility of combining accurate predictions with a limited number of laboratory experiments is illustrated by practical examples. These include the identification of T-cell epitopes from IDDM-, melanoma- and malaria-related antigens by combining computational and conventional laboratory assays. The success rate in determining antigenic peptides, each in the context of a specific HLA molecule, ranged from 27 to 7 1%, while the natural prevalence of MHC-binding peptides is 0.1-5%.

AB - Computer models can be combined with laboratory experiments for the efficient determination of (i) peptides that bind MHC molecules and (ii) T- cell epitopes. For maximum benefit, the use of computer models must be treated as experiments analogous to standard laboratory procedures. This requires the definition of standards and experimental protocols for model application. We describe the requirements for validation and assessment of computer models. The utility of combining accurate predictions with a limited number of laboratory experiments is illustrated by practical examples. These include the identification of T-cell epitopes from IDDM-, melanoma- and malaria-related antigens by combining computational and conventional laboratory assays. The success rate in determining antigenic peptides, each in the context of a specific HLA molecule, ranged from 27 to 7 1%, while the natural prevalence of MHC-binding peptides is 0.1-5%.

KW - Antigenic peptides

KW - Computer models

KW - HLA

KW - MHC

KW - Prediction

KW - T-cell epitopes

UR - http://www.scopus.com/inward/record.url?scp=0032825083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032825083&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 313

EP - 324

JO - International Journal of Peptide Research and Therapeutics

JF - International Journal of Peptide Research and Therapeutics

SN - 1573-3149

IS - 5-6

ER -